Retatrutide TRIUMPH-2 Trial Reports 19.8% Weight Loss in Type 2 Diabetes
New Phase 3 trial data published in TRIUMPH-2 PubMed record this week shows Eli Lilly's retatrutide helped adults with both type 2 diabetes and obesity lose up to 19.8% of their body